Summary of Study ST003137

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001950. The data can be accessed directly via it's Project DOI: 10.21228/M8NX50 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST003137
Study TitleLipid class-specific kinetics of plasma fatty acids, oxylipins, endocannabinoids, lysophospholipids and bile acids upon a lipopolysaccharide challenge of healthy humans and their modulation by anti-oxidative supplements (Part 1/2 - negative mode)
Study SummaryWhile molecular mechanisms of inflammatory processes are well characterized, the systemic responses of humans exposed to pathogen-associated molecular pattern with regard to fatty acid derivatives and other lipids have hardly been determined. Here, we present a dual stage controlled clinical intervention study with healthy individuals challenged with lipopolysaccharide. While in a first stage, plasma proteomics and lipidomics was applied to observe the kinetics of inflammatory modulators within eight hours, the effects of a placebocontrolled anti-oxidative intervention were determined in the second stage. Plasma proteome profiling demonstrated the early involvement of platelets detectable within two hours after lipopolysaccharide challenge, followed by the characteristic induction of liver-derived acute phase proteins and innate immune cell-derived alarmins. Untargeted lipidomics demonstrated the early release of fatty acids and taurocholic acid within two hours, followed by complex time courses of various oxylipins and the downregulation of numerous lysophospholipids and deoxycholic acid. Groups of molecules with similar kinetics during the time course analysis upon lipopolysaccharide challenge were observed to have common precursors or synthesizing enzymes. Dietary supplementation with antioxidants did not affect the kinetics of detectable proteins, but significantly downregulated the pro-inflammatory sphingosine-1-phosphate and increased the levels of oxylipins described to facilitate the resolution of inflammation, 20-HEPE and 22-HDoHE. The present study identified a complex network of oxylipins, bile acids, lysophospholipids and endocannabinoids deregulated in plasma upon lipopolysaccharide challenge, introduces platelets as powerful inflammatory modulators and suggests that dietary antioxidant supplementation hardly interferes with the induction of inflammatory processes, but may rather support the resolution of inflammation.
Institute
University of Vienna
DepartmentDepartment of Analytical Chemistry
LaboratoryGerner lab
Last NameHagn
First NameGerhard
AddressWähringerstraße 38, 1090 Vienna, Austria
Emailgerhard.hagn@univie.ac.at
Phone+43 1 4277 52375
Submit Date2024-03-18
Raw Data AvailableYes
Raw Data File Type(s)mzML, raw(Thermo)
Analysis Type DetailLC-MS
Release Date2025-06-02
Release Version1
Gerhard Hagn Gerhard Hagn
https://dx.doi.org/10.21228/M8NX50
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Factors:

Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)

mb_sample_id local_sample_id Treatment
SA339888Donor33_stage1_480_min_con_1con
SA339889Donor25_stage1_480_min_con_2con
SA339890Donor25_stage1_480_min_con_1con
SA339891Donor25_stage1_240_min_con_2con
SA339892Donor25_stage1_240_min_con_1con
SA339893Donor33_stage1_120_min_con_2con
SA339894Donor33_stage1_240_min_con_1con
SA339895Donor25_stage1_120_min_con_2con
SA339896Donor24_stage1_60_min_con_1con
SA339897Donor33_stage1_0_min_con_1con
SA339898Donor33_stage1_480_min_con_2con
SA339899Donor33_stage1_240_min_con_2con
SA339900Donor33_stage1_0_min_con_2con
SA339901Donor32_stage1_60_min_con_1con
SA339902Donor24_stage1_240_min_con_1con
SA339903Donor24_stage1_120_min_con_2con
SA339904Donor24_stage1_120_min_con_1con
SA339905Donor24_stage1_60_min_con_2con
SA339906Donor24_stage1_240_min_con_2con
SA339907Donor24_stage1_480_min_con_1con
SA339908Donor24_stage1_480_min_con_2con
SA339909Donor25_stage1_0_min_con_1con
SA339910Donor25_stage1_0_min_con_2con
SA339911Donor25_stage1_60_min_con_1con
SA339912Donor32_stage1_480_min_con_2con
SA339913Donor33_stage1_60_min_con_1con
SA339914Donor32_stage1_60_min_con_2con
SA339915Donor33_stage1_60_min_con_2con
SA339916Donor33_stage1_120_min_con_1con
SA339917Donor25_stage1_60_min_con_2con
SA339918Donor32_stage1_120_min_con_1con
SA339919Donor32_stage1_120_min_con_2con
SA339920Donor32_stage1_480_min_con_1con
SA339921Donor32_stage1_240_min_con_2con
SA339922Donor32_stage1_240_min_con_1con
SA339923Donor25_stage1_120_min_con_1con
SA339924Donor26_stage1_480_min_con_1con
SA339925Donor28_stage1_0_min_con_1con
SA339926Donor27_stage1_480_min_con_2con
SA339927Donor28_stage1_0_min_con_2con
SA339928Donor29_stage1_480_min_con_2con
SA339929Donor29_stage1_240_min_con_2con
SA339930Donor29_stage1_480_min_con_1con
SA339931Donor27_stage1_480_min_con_1con
SA339932Donor27_stage1_240_min_con_2con
SA339933Donor30_stage1_0_min_con_1con
SA339934Donor30_stage1_0_min_con_2con
SA339935Donor27_stage1_60_min_con_2con
SA339936Donor27_stage1_120_min_con_1con
SA339937Donor27_stage1_240_min_con_1con
SA339938Donor27_stage1_120_min_con_2con
SA339939Donor29_stage1_240_min_con_1con
SA339940Donor29_stage1_120_min_con_2con
SA339941Donor28_stage1_480_min_con_1con
SA339942Donor28_stage1_240_min_con_2con
SA339943Donor28_stage1_480_min_con_2con
SA339944Donor24_stage1_0_min_con_2con
SA339945Donor29_stage1_0_min_con_1con
SA339946Donor29_stage1_0_min_con_2con
SA339947Donor28_stage1_240_min_con_1con
SA339948Donor28_stage1_120_min_con_2con
SA339949Donor29_stage1_60_min_con_2con
SA339950Donor29_stage1_120_min_con_1con
SA339951Donor29_stage1_60_min_con_1con
SA339952Donor28_stage1_60_min_con_1con
SA339953Donor28_stage1_120_min_con_1con
SA339954Donor28_stage1_60_min_con_2con
SA339955Donor27_stage1_60_min_con_1con
SA339956Donor27_stage1_0_min_con_2con
SA339957Donor31_stage1_120_min_con_1con
SA339958Donor31_stage1_120_min_con_2con
SA339959Donor31_stage1_60_min_con_2con
SA339960Donor31_stage1_60_min_con_1con
SA339961Donor31_stage1_0_min_con_1con
SA339962Donor31_stage1_0_min_con_2con
SA339963Donor31_stage1_240_min_con_1con
SA339964Donor31_stage1_240_min_con_2con
SA339965Donor26_stage1_0_min_con_1con
SA339966Donor32_stage1_0_min_con_1con
SA339967Donor26_stage1_0_min_con_2con
SA339968Donor26_stage1_60_min_con_1con
SA339969Donor31_stage1_480_min_con_1con
SA339970Donor31_stage1_480_min_con_2con
SA339971Donor26_stage1_60_min_con_2con
SA339972Donor26_stage1_120_min_con_1con
SA339973Donor30_stage1_120_min_con_2con
SA339974Donor30_stage1_240_min_con_1con
SA339975Donor30_stage1_120_min_con_1con
SA339976Donor30_stage1_60_min_con_2con
SA339977Donor27_stage1_0_min_con_1con
SA339978Donor30_stage1_60_min_con_1con
SA339979Donor30_stage1_240_min_con_2con
SA339980Donor30_stage1_480_min_con_1con
SA339981Donor26_stage1_240_min_con_1con
SA339982Donor26_stage1_120_min_con_2con
SA339983Donor26_stage1_240_min_con_2con
SA339984Donor26_stage1_480_min_con_2con
SA339985Donor30_stage1_480_min_con_2con
SA339986Donor32_stage1_0_min_con_2con
SA339987Donor19_stage1_0_min_con_1con
Showing page 1 of 6     Results:    1  2  3  4  5  Next  Last     Showing results 1 to 100 of 599
  logo